← Back to headlines
GLP-1 Drugs' Cold Chain Requirement Boosts UPS and FedEx Growth
The necessity for GLP-1 drugs to remain cold is emerging as a significant growth driver for logistics giants United Parcel Service, Inc. (UPS) and FedEx Corporation (FDX). This requirement creates new opportunities in cold chain logistics.
27 Jul, 19:03 — 27 Jul, 19:03
Sources
Showing 1 of 1 sources
Related Stories
Corporate Dividend Declarations Include Nvidia, Mosaic, and Alamos Gold
21m ago
Build-A-Bear Cuts Revenue Guidance and Slashes Shares After Weak Summer Sales
21m ago
Major Canadian Banks Report Strong Third-Quarter Earnings, Beating Forecasts
47m ago
Anthropic Introduces Framework for AI Agents to Control Physical Devices
1h ago